Table 4. Univariate logistic regression for T2DM microvascular complications.
| Variables | Diabetic retinopathy | Diabetic neuropathy | Diabetic nephropathy | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |||
| Gender (female) | 1.20 (1.03–1.40) | 0.019 | 1.08 (9.47–1.24) | 0.235 | 0.84 (0.70–1.02) | 0.079 | ||
| Age | 1.02 (1.01–1.03) | <0.001 | 1.01 (1.00–1.02) | <0.001 | 1.01 (1.00–1.02) | 0.001 | ||
| Smoking | 1.04 (0.84–1.29) | 0.675 | 1.58 (1.33–189) | <0.001 | 1.27 (0.99–1.62) | 0.055 | ||
| Drinking | 0.80 (0.61–1.06) | 0.131 | 1.15 (0.92–1.45) | 0.206 | 0.87 (0.62–1.22) | 0.438 | ||
| Family history of T2DM | 1.12 (0.95–1.31) | 0.153 | 1.44 (1.25–1.66) | <0.001 | 1.30 (1.08–1.58) | 0.005 | ||
| BMI | 0.99 (0.97–1.01) | 0.493 | 0.99 (0.97–1.01) | 0.472 | 1.01 (0.99–1.03) | 0.106 | ||
| Duration | 1.07 (10.50–1.08) | <0.001 | 1.05 (1.04–1.06) | <0.001 | 1.06 (1.05–1.08) | <0.001 | ||
| Insulin use | 1.66 (1.31–2.09) | <0.001 | 1.29 (1.03–1.60) | 0.023 | 1.61 (1.22–2.12) | 0.001 | ||
| Hypertension | 2.83 (2.42–3.32) | <0.001 | 3.68 (3.18–4.25) | <0.001 | 4.03 (3.29–4.94) | <0.001 | ||
| Dyslipidemia | 2.89 (2.43–3.43) | <0.001 | 2.40 (2.05–2.82) | <0.001 | 4.91 (4.03–5.99) | <0.001 | ||
| Regular exercise | 0.90 (0.76–1.05) | 0.202 | 0.64 (0.55–0.75) | <0.001 | 0.69 (0.56–0.85) | 0.001 | ||